| View Archive: 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 February 2, 2010
Gilead Sciences to Present at the 12th Annual BIO CEO Investor Conference on Tuesday, February 9
January 29, 2010
Gilead Announces Share Repurchase Program
January 28, 2010
Per Wold-Olsen Joins Gilead Sciences' Board of Directors
January 27, 2010
Gilead Sciences Announces Notification of ANDA Filing for Viread® January 26, 2010
Gilead Sciences Announces Record Fourth Quarter and Full Year 2009 Financial Results
January 19, 2010
Gilead Sciences to Release Fourth Quarter and Year End 2009 Financial Results on Tuesday, January 26, 2010 January 6, 2010
Phase II Clinical Trial of Gilead's Investigational Integrase-Based, Once-Daily, Fixed-Dose "Quad"Regimen Meets 24-Week Primary Objective January 4, 2010
Gilead Sciences to Present at Two Upcoming Investor Conferences |
